Cartherics granted first US patent for multiple development candidates
By Christine Filippis / October 6, 2022
Melbourne, Australia, 06 October 2022 – Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced...
Read More
Cartherics-led Consortium Receives $5.4M Federal Funding for Cellular Immunotherapy Research into Ovarian and Gastric Cancers
By Christine Filippis / September 30, 2022
MELBOURNE, Australia, 27 September 2022 – Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, together...
Read More
3 Cheers for a Cartherics Board Member
By Christine Filippis / June 16, 2022
Bryan Williams ranked among the world’s most prominent scientists By Leigh Dayton, 16 June 2022 Cartherics is delighted to announce...
Read More
She’s an Adventurer, Advocate, Author and a Cancer Survivor
By Christine Filippis / June 9, 2022
Now Heather Hawkins is a member of the Cartherics Board By Leigh Dayton 9 June 2022 It’s official. As of...
Read More
Presentation at the Locust Walk Stem Cell Tx Conference
By carth_admin / April 8, 2022
Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner...
Read More
Congratulations to Cartherics CEO
By carth_admin / April 1, 2022
Alan Trounson is ranked among the world’s most prominent scientists
Read More
Cartherics CEO discusses the importance of industry-academic collaboration with new partner
By carth_admin / March 30, 2022
In the following interview with ARMI Alan Trounson discusses the importance and challenges of translation
Read More
7th Innate Killer Summit 2022, Dr Nicholas Boyd Presenting
By Christine Filippis / March 25, 2022
7th Innate Killer Summit (San Diego, California) Cartherics Chief Development Officer, Dr Nicholas Boyd The innate cell therapy field is...
Read More
By Christine Filippis / March 4, 2022
The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical development, translation, manufacturing, supply and storage of allogeneic cell therapies to improve the...
Read More
Presentation at the Next Generation CAR-TCR Summit (London, UK)
By Christine Filippis / February 23, 2022
Presentation at the Next Generation CAR-TCR Summit (London, UK) Cartherics Chief Development Officer, Dr Nicholas Boyd CAR-T immunotherapy has exploded...
Read More
Presentation: Multi-Functional Cell Therapies Summit
By Christine Filippis / January 27, 2022
Chief Development Officer, Dr Nicholas Boyd Cell therapies have the potential to not only be life-saving but curative for a...
Read More
The Right Time & The Right Place
By Christine Filippis / January 20, 2022
Cartherics welcomes a new Senior Research Fellow who says she has finally found The Right Job By Leigh Dayton, 20...
Read More
‘Off-the-Shelf’ Immunotherapy Gets Special Treatment in Special Issue of The Journal Cells
By Christine Filippis / January 17, 2022
Thanks go to Special Editor, Cartherics CEO Alan Trounson By Leigh Dayton, 17 January 2022 Cellular immunotherapy is revolutionizing cancer...
Read More
A Star is Born! Cartherics student takes out top award …..
By Christine Filippis / January 4, 2022
By Leigh Dayton, 4 January 2022 When Cartherics Biomedical Honours student Elizabeth (Liz) Bakaniozos opened an e-mail this month from...
Read More
Three Cheers for the CARTeam!
By Christine Filippis / December 6, 2021
By Leigh Dayton, 6 December 2021 When eight Cartherics women first teamed-up to walk or run 4km every day in...
Read More
